Who should measure quality of life, the doctor or the patient?
M. L. Slevin;H. Plant;D. Lynch;J. Drinkwater.
British Journal of Cancer (1988)
Mental health of hospital consultants: the effects of stress and satisfaction at work
A J Ramirez;J Graham;M A Richards;A Cull.
The Lancet (1996)
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
M L Slevin;L Stubbs;H J Plant;P Wilson.
Burnout and psychiatric disorder among cancer clinicians.
Amanda-Jane Ramirez;Jill Graham;Michael Richards;A Cull.
British Journal of Cancer (1995)
Follicular lymphoma: prognostic factors for response and survival.
C J Gallagher;W M Gregory;A E Jones;A G Stansfeld.
Journal of Clinical Oncology (1986)
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
Gareth J Morgan;Faith E Davies;Walter M Gregory;Kim Cocks.
The Lancet (2010)
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
M L Slevin;P I Clark;S P Joel;S Malik.
Journal of Clinical Oncology (1989)
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
Richard J. Kelly;Anita Hill;Louise M. Arnold;Gemma L. Brooksbank.
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
Brian A. Walker;Eileen M. Boyle;Christopher P. Wardell;Alex Murison.
Journal of Clinical Oncology (2015)
Breast-Cancer Adjuvant Therapy with Zoledronic Acid
Robert E. Coleman;Helen Marshall;David Cameron;David Dodwell.
The New England Journal of Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: